Bridgewater Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-137,907
Closed -$1.81M 821
2023
Q3
$1.81M Buy
137,907
+13,871
+11% +$182K 0.01% 510
2023
Q2
$1.56M Sell
124,036
-10,946
-8% -$133K 0.01% 507
2023
Q1
$1.76M Buy
134,982
+94,615
+234% +$1.53M 0.01% 481
2022
Q4
$712K Buy
+40,367
New +$676K ﹤0.01% 681

Other funds holding MDRX

Bridgewater Associates's MDRX Position: Q4 2023 in Review

Bridgewater Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2023, closing a stake of 137,907 shares — an estimated $1.81M sold.

Bridgewater Associates first reported a position in MDRX in Q4 2022 and held it in 4 quarters. The position peaked at $1.81M in Q3 2023. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.

  • Bridgewater Associates reported no remaining Veradigm Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bridgewater Associates sold 137,907 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $1.81M.
  • Bridgewater Associates first reported a position in Veradigm Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Bridgewater Associates's Veradigm Inc. Common Stock position peaked at $1.81M in Q3 2023.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.

Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.